JP Morgan Upgrades Adient to Overweight, Lowers Price Target to $25

Benzinga · 2d ago
JP Morgan analyst Rajat Gupta upgrades Adient (NYSE:ADNT) from Neutral to Overweight and lowers the price target from $28 to $25.